The White House search for the next Federal Reserve chair continues to twist and turn, with BlackRock bond chief Rick Rieder emerging as the latest hot candidate. The firm's chief investment officer of global fixed income interviewed Friday with Treasury Secretary Scott Bessent, the Trump administration's point man for Jerome Powell's successor.

Royalty Pharma remains a Buy supported by strong execution and upward guidance revision. RPRX trades at a significant valuation discount to biopharma peers, with 86% of its portfolio in approved therapies and robust free cash flow growth. Management projects 11–14% portfolio receipts CAGR through 2030, exceeding consensus, and demonstrates disciplined capital allocation with M&A capability.

SLR Investment Corp. delivered a solid, as-expected quarter with minor NAV and NII outperformance, maintaining consistent performance and decent valuation. SLRC's portfolio growth, stable credit quality, and rising weighted average yield support continued dividend stability, with no new non-accruals and credit risk well-managed. The unchanged $0.41 quarterly dividend is likely to persist, supported by a healthy UTI balance and prudent leverage, distinguishing SLRC from more volatile BDC peers.

A breakup of the $50 billion seed-and-pesticide maker could usher in a dealmaking wave in agriculture not seen since the first Trump administration.

Initiating coverage on Travere Therapeutics with a "Buy: rating, citing strong growth potential for its kidney drug Filspari (sparsentan). Company's Filspari is FDA-approved for IgAN, with Q2 2025 U.S. net product revenues growing by 165% year-over-year to $71.9 million. A key catalyst is the January 13, 2026 PDUFA date for Filspari's sNDA in FSGS, potentially making it the first approved treatment for this rare kidney disorder.

Otis Worldwide Corporation (NYSE:OTIS ) Morgan Stanley's 13th Annual Laguna Conference September 12, 2025 1:00 PM EDT Company Participants Judith Marks - Chair, President & CEO Conference Call Participants Christopher Snyder - Morgan Stanley, Research Division Presentation Christopher Snyder Equity Analyst Well, thank you, everybody. Chris Snyder, U.S. multi-industry analyst.

The crypto exchange jumped 43% in volatile trading in its Nasdaq debut, the latest upside surprise in the resurgent IPO market.

Stellantis is axing its Ram 1500 electric pickup, citing slow demand for full-size EV trucks, the company said Friday.

iShares International Equity Factor ETF offers diversified exposure to ex-U.S. developed markets, emphasizing momentum, quality, value, and low volatility factors. INTF has outperformed its benchmark EFA since inception and delivered strong recent returns, but some competitors like QEFA and IDMO have superior performance. The fund features a low expense ratio, a value tilt, and robust dividend growth, though its drawdowns are deeper than some peers.

Apple delayed the launch of its iPhone Air in mainland China, citing regulatory approval issues, in a setback for a high-profile new product. Bloomberg's Mark Gurman joins Caroline Hyde with the details on "Bloomberg Tech.

The US FTC is investigating whether Amazon and Google misled advertisers about the terms and pricing for ads on their websites. Bloomberg's Mike Shepard joins Caroline Hyde on "Bloomberg Tech.

Apple Inc (NASDAQ:AAPL, ETR:APC) is seeing strong early demand for its newly unveiled iPhone 17 lineup, according to analysts at Wedbush, who reiterated their ‘Outperform' rating and $270 price target on the stock. Shares traded hands at $233 on Friday afternoon.

MORT is rated a buy due to its superior yield, historical performance, and lower expense ratio versus REM, rated a hold. MORT offers a higher, sustainable dividend yield (11.67%) and better diversification across holdings, making it attractive for income-focused investors. Favorable rate cut projections and declining mortgage rates create a strong tailwind for mortgage REITs, supporting both income and capital appreciation potential.

It was a busy week on Wall Street marked by Oracle earnings, and a slew of individual news items. Looking ahead, all eyes will be on the Fed's interest-rate decision next week.

Also: The scorching IPO market, an IRA problem you wish you had, and your residential real-estate questions answered

SAN DIEGO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025.

Tesla , the electric vehicle company led by billionaire Elon Musk, was accused in a lawsuit on Friday of favoring visa holders over Americans when making employment decisions so it can pay less.

The market has staged a dramatic comeback in recent months, but Kevin Matras believes the rest of 2025 could be even more spectacular. Learn how to take advantage of what's shaping up to be another year of double-digit returns.

EMCOR Group, Inc. (NYSE:EME ) Morgan Stanley's 13th Annual Laguna Conference September 12, 2025 11:30 AM EDT Company Participants Anthony Guzzi - Chairman, President & CEO Jason Nalbandian - Senior VP, CFO & Chief Accounting Officer Presentation Unknown Analyst All right. I think we're ready.

MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.